Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Stuttering
NCT07296328Phase 2Not yet recruiting
- Sponsor
- NYU Langone Health
- Start
- Jan 2026
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in stuttering, sponsored by NYU Langone Health. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
stuttering
Beyond the preview
Go deeper on NCT07296328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07296328.